Lilly is moving against sellers of copycat versions of its unapproved triple agonist, the latest step in the push against gray market retatrutide.
Recap by typeshit. Full story at The Washington Post.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
Covers hair and nail findings, vision loss lawsuits Novo and Lilly dispute, and new WHO guidance against obesity drugs for kids under 10.
A case study describes a rare but life-threatening complication linked to weight loss medications. Full details are in the NewsNation report.
Loading…